The use of radioimmunoconjugates in stem cell transplantation. (Q34679582)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12058230%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

The use of radioimmunoconjugates in stem cell transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12058230%20AND%20SRC:MED&resulttype=core&format=json

stem cell transplantation

9 November 2019

main subject

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12058230%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Frederick R. Appelbaum

series ordinal

object named as

Appelbaum FR

1 reference

9 November 2019

Pagel JM

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12058230%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Matthews DC

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12058230%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Bernstein ID

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12058230%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12058230%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12058230%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12058230%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12058230%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

807-816

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12058230%20AND%20SRC:MED&resulttype=core&format=json

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

Physics for practitioners: the use of radiolabeled monoclonal antibodies in B-cell non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

Human homologue of murine T200 glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first compl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

Survival of patients with resistant Hodgkin's disease after polyclonal yttrium 90-labeled antiferritin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal cancers: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

Systemic radiotherapy in metastatic breast cancer using 90Y-linked monoclonal MUC-1 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

Transport of fluid and macromolecules in tumors. IV. A microscopic model of the perivascular distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

Tumor therapy with targeted atomic nanogenerators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL): initial phase I/II study results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

In vivo 'Purging' of residual disease in CLL with Campath-1H

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

7 January 2021

A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

7 January 2021

The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

7 January 2021

Immunologic Markers in the Differential Diagnosis of Small Round Cell Tumors from Lymphocytic Lymphoma and Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

7 January 2021

CD66c antigen expression is myeloid restricted in normal bone marrow but is a common feature of CD10+ early-B-cell malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

7 January 2021

Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

7 January 2021

Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

7 January 2021

Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

7 January 2021

Radioimmunotherapy with alpha-emitting nuclides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

7 January 2021

A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703524

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703524

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12058230%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 November 2019

1045239184

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12058230%20AND%20SRC:MED&resulttype=core&format=json